Parallel Advisors’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $332 | Hold |
465
| – | – | ﹤0.01% | 3335 |
|
2025
Q1 | $303 | Hold |
465
| – | – | ﹤0.01% | 3311 |
|
2024
Q4 | $856 | Hold |
465
| – | – | ﹤0.01% | 3117 |
|
2024
Q3 | $1.61K | Hold |
465
| – | – | ﹤0.01% | 2921 |
|
2024
Q2 | $1.36K | Hold |
465
| – | – | ﹤0.01% | 2878 |
|
2024
Q1 | $2.63K | Hold |
465
| – | – | ﹤0.01% | 2740 |
|
2023
Q4 | $2K | Sell |
465
-65
| -12% | -$279 | ﹤0.01% | 2809 |
|
2023
Q3 | $1.84K | Buy |
530
+1
| +0.2% | +$3 | ﹤0.01% | 2851 |
|
2023
Q2 | $2.46K | Buy |
529
+64
| +14% | +$298 | ﹤0.01% | 2695 |
|
2023
Q1 | $2.15K | Hold |
465
| – | – | ﹤0.01% | 2749 |
|
2022
Q4 | $3.76K | Hold |
465
| – | – | ﹤0.01% | 2450 |
|
2022
Q3 | $3K | Hold |
465
| – | – | ﹤0.01% | 2509 |
|
2022
Q2 | $2K | Hold |
465
| – | – | ﹤0.01% | 2623 |
|
2022
Q1 | $4K | Hold |
465
| – | – | ﹤0.01% | 2394 |
|
2021
Q4 | $7K | Hold |
465
| – | – | ﹤0.01% | 2267 |
|
2021
Q3 | $9K | Hold |
465
| – | – | ﹤0.01% | 2116 |
|
2021
Q2 | $9K | Hold |
465
| – | – | ﹤0.01% | 2041 |
|
2021
Q1 | $11K | Buy |
+465
| New | +$11K | ﹤0.01% | 1870 |
|